Anti-B3GALT5 antibodies are used in the immunodetection of the protein beta-1,3-galactosyltransferase 5. In humans, the canonical protein has a reported length of 310 amino acid residues and a mass of 36.2 kDa. Its subcellular localization is in the Golgi. It is reported to be expressed in the stomach, jejunum, colon, pancreas, small intestine, testis and gastrointestinal and pancreatic cancer cell lines. A member of the Glycosyltransferase 31 protein family, B3GALT5 is known to catalyze the transfer of Gal to GlcNAc-based acceptors with a preference for the core3 O-linked glycan GlcNAc(beta1,3)GalNAc structure. Synonyms for this target antigen include B3GalTx, B3T5, GLCT5, beta-1,3-GalTase 5, beta-3-Gx-T5, and B3GalT-V. B3GALT5 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. A number of B3GALT5 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Flow Cytometry are also common applications.